Login
$NAGE
$1.96 -$0.05 (2.49%) After hours

$NAGE SEC Filings

Filed On Filing
04 Nov 2026 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Launched Niagen NanoCloud™, the first dermatologist-tested topical product

04 Aug 2026 10-Q
04 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Launched pharmaceutical program targeting rare genetic diseases and aging related disorders in July

29 Jul 2026 SCHEDULE 13G
10 Jul 2026 PROSPECTUS SUPPLEMENT
09 Jul 2026 EFFECT
08 Jul 2026 Form 4: Lopez Carlos Luis, SVP, General Counsel

Received 2,314 shares as a grant or award ($6.27K)

08 Jul 2026 Form 4: Pamir Ozan, Chief Financial Officer

Received 4,255 shares as a grant or award ($11.5K)

08 Jul 2026 Form 4: Fried Robert N, Director

Received 1,106 shares as a grant or award ($3K)

29 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

Set forth below are the results of the matters submitted for a vote of stockholders at the Company’s 2026 Annual Meeting.

29 Jun 2026 REGISTRATION STATEMENT
26 Jun 2026 Form 4: Yu Wing Tak Wendy, Director

Granted 31,746 Stock Option (right to buy)

26 Jun 2026 Form 4: Ng Wang Yu Gary, Director

Granted 31,746 Stock Option (right to buy)

26 Jun 2026 Form 4: Cohen Ann, Director

Granted 31,746 Stock Option (right to buy)

26 Jun 2026 Form 4: Patrick Kristin, Director

Granted 31,746 Stock Option (right to buy)

26 Jun 2026 Form 4: Shahbazi Hamed, Director

Granted 31,746 Stock Option (right to buy)

26 Jun 2026 Form 4: Rubin Steven D, Director

Granted 31,746 Stock Option (right to buy)

26 Jun 2026 Form 4: Jaksch Frank L Jr, Director

Granted 31,746 Stock Option (right to buy)

06 May 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Net income of $6.3 million, up $1.3 million from the prior year and adjusted EBITDA of $3.8 million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support